Intarcia Therapeutics logo

Intarcia Therapeutics Funding & Investors

Boston, MA

Intarcia Therapeutics is an American biopharmaceutical company based in Boston, MA and incorporated under the laws of Delaware. It was founded in 1995 under the name "BioMedicines" and changed to its present name in 2004. In 2013, Intarcia relocated its headquarters to Boston, keeping its manufacturing facility in Hayward, CA. In addition to Boston and Hayward, Intarcia also has a location in Research Triangle Park, North Carolina, where it discovers and develops peptides for its drug delivery system.

https://www.intarcia.com/

Total Amount Raised: $1,683,530,880

Intarcia Therapeutics Funding Rounds

  • Debt Financing

    $73,125,000

  • Series E

    $200,000,000

  • Series E

    $206,000,000

    Series E Investors

    Bill & Melinda Gates Foundation
    GWC Innovator Fund
  • Series E

    $215,000,000

    Series E Investors

    Baillie Gifford
    Kayon Partners
    Baupost Group
    Fidelity
    Foresite Capital
    RA Capital Management
    The Pritzker Organization
    NXT Ventures
  • Debt Financing

    $75,000,000

    Debt Financing Investors

    Midcap Financial
    First Citizens Bank
  • Series Unknown

    $225,000,000

  • Series Unknown

    $200,000,000

    Series Unknown Investors

    RA Capital Management
    Foresite Capital
    Farallon Capital Management
    Alger
    New Leaf Venture Partners
    Quadrille Capital
  • Series Unknown

    $160,000,000

    Series Unknown Investors

    Notable Capital
    Marker
    Venrock
    NEA - New Enterprise Associates
    New Leaf Venture Partners
    Farallon Capital Management
    Baupost Group
  • Debt Financing

    $50,000,000

    Debt Financing Investors

    NEA - New Enterprise Associates
    Venrock
    New Leaf Venture Partners
    Baupost Group
    Farallon Capital Management
  • Debt Financing

    $45,791,354

  • Debt Financing

    $5,000,000

    Debt Financing Investors

    New Leaf Venture Partners
    NEA - New Enterprise Associates
    Venrock
  • Series Unknown

    $14,488,394

    Series Unknown Investors

    Greenspring Associates
  • Series Unknown

    $9,026,189

  • Series Unknown

    $50,000,000

    Series Unknown Investors

    New Leaf Venture Partners
    Alta Partners
    NEA - New Enterprise Associates
    Quadrille Capital
    Omega Fund Management
    Notable Capital
    Venrock
  • Debt Financing

    $10,000,000

    Debt Financing Investors

    Horizon Technology Finance
    First Citizens Bank
  • Series E

    $50,000,000

    Series E Investors

    Notable Capital
    Venrock
    Alta Partners
    NEA - New Enterprise Associates
    InterWest Partners
  • Series D

    $43,000,000

    Series D Investors

    Venrock
    Alta Partners
    NEA - New Enterprise Associates
    InterWest Partners
  • Series C

    $38,000,000

    Series C Investors

    InterWest Partners
    Alta Partners
  • Series B

    $12,100,000

    Series B Investors

    Alta Partners
    InterWest Partners
  • Series A

    $2,000,000

Funding info provided by Diffbot.